Insider Transactions in Q4 2021 at Cortexyme, Inc. (CRTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2021
|
Casey Lynch Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+35.32%
|
$0
$0.46 P/Share
|
|
Nov 16
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+25.0%
|
$60,000
$2.23 P/Share
|
|
Nov 12
2021
|
Stephen S. Dominy Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
763
+0.06%
|
$10,682
$14.4 P/Share
|
|
Oct 08
2021
|
Margaret Mc Loughlin |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$88,000
$88.93 P/Share
|
|
Oct 08
2021
|
Margaret Mc Loughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$17,000
$17.0 P/Share
|
|
Oct 05
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
SELL
Open market or private sale
|
Direct |
4,963
-7.64%
|
$486,374
$98.5 P/Share
|
|
Oct 05
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,963
+7.1%
|
$268,002
$54.85 P/Share
|